FDA Investigator CDR Thomas R Berry, PPh

CDR Thomas R Berry, PPh has inspections in 8 countries as of 01 Sep 2023. CDR Thomas R Berry, PPh has collaborated with a combinined 4440 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
113
Last Inspection Date:
01 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
Belgium, United States of America, Netherlands, Spain, Germany, Canada, France, Austria
Co-Investigator(s):
Aaron P Wozniak, Adam R Cooke, Alice S Tsao, Amy H Ruble, Anissa M Vargas, Arthur G Hurst, Azza Talaat, Babatunde D Babalola, Barbara M Frazier, Barbara M Frazir, Beth F Fritch, Betsy C Galliher, Billy M Battles, Bonita S Chester, Brandy D Brown, Bridegan, Brittny C Cargo, Brown, Buford, Burnell M Henry, Calvin B Koerner, Carlos A Ortiz, Carlos M Gonzalez, Carol F Robinson, Carolyn A Renshaw, CDR Rochelle B Young, RPh, MSA, CDR Sean T Creighton, Charanjeet Jassal, Charles M Edwards, Cherrie A Zachary, Cheryl D Barton, Chestnut, Christian D Lynch (CDL), Christina A Miller, Christopher J Adams, Christopher S Keating, Claire M Minden, Claudette D Brooks, Contractor Bridgers, Cynthia Jim, CSO, Daphne Santiago, PhD, Darcy E Brillhart, Dawn M Braswell, Denise M Digiulio, Derek C Price, Devaugh Edwards, Devaughn Edwards, Donald C Obenhuber, PhD, Dr. Gang Wang, PhD, Dr. Ralph M Bernstein, PhD, Dr. Sriram Subramaniam, PhD, Edward Deberry, Edwin Martinez, Eileen J Bannerman, Eric S Clevenger, Eric S Weilage, Erin C Hill, Ernest H Blackwood, Esra Toussaint, Fabian Nchaparro Rodriguez, Frank Wackes, Gabriel R Mclemore, Gamal A Norton, Gary E Coleman, Jr, REHS, Gene D Arcy, Geraldine D Sanders, Gerraldine Sanders, Gideon N Esuzor, Gilbert T Salud, Hai L Phung, Hai Lien Phung, Hai Lien T Phung, Harmon, Harshal J Desai, Hector A Carrero, Hei Lient Phung, Helen B Ricalde, Ibad U Khan, Igbinoba, Inga M Warr, Jacqueline D Mitchell, Jacqueline Mdiaz Albertini, James A Liubicich, James P Lewis, Jr, James R Evans, Jamirya S Weatherly, Jaqueline Mitchell, Jared P Stevens, Jason F Chancey, Jawaid Hamid, Jennifer D Hollstrom, Jie He, Joanne T Gabay, Joe A Odom, John A Gonzalez, Johnetta F Walters, Jonathan G Swoboda, Jones, Jose Acruz Gonzalez, Joseph F Owens, Joseph Kutze, PhD, Kara D Dobbin, Karen A Coleman, Kassa Ayalew, MD, Kathleen D Culver, Katrina B Mosley Sloan, Kelli F Dobilas, Kemejumaka N Opara, Kirsten L Vadheim, PhD, Lakeesha M Foster, Larry K Hampton, Laura D Cain, Laura I Salazar, PhD, Laura L Staples, Lauren N Howard, Laurie Nelson, Lauryl A Smith, Lawrence Carter, III, Lawrence S Newsom, Leah Andrews, Leah M Andrews, Lei Zhang, PhD, Leo J Lagrotte, Lesley K Satterwhite, Libia M Lugo, Lois K Gross, LT Daveta L Bailey, LT Tamara J Henderson, Luis A Carrion, Luis M Burgos Medero, Lynda L Lanning, Mancia R Walker, Marcia A Worley, Marcia Gelber, Marie F Mathews, Marie F Morin, Marion Michaelis, Marisa E Stock, Marla A Cassidy, Marla A Long, Marvin D Jones, Melanie M Walker, Melanie W Pishnery, Metitia G Sanders, Metitia M Gramby, Miaja Umaedi, Michael F Skelly, PhD, Michele L Forster, PhD, Michelle D Haamid, Michelle Haamid, Michelle Y Clark Stuart, Monica Cburgos Garcia, Morrell, Narong Chamkasem, PhD, Neali H Lucas, Nebil A Oumer, Nicole A Lloyd, Nicole E Knowlton, Nicole M Bell, Noreen Muniz, Nydia E Colon, Omotunde O Osunsanmi, Panney H Mccarver, Patricia F Hudson, Patrick L Wisor, Paul A Bonneau, Paul W Moy, Paula A Trost, Penny H Mccarver, Perry H Gambrell, Philip F Istafanos, DMV, MS, Prabhu P Raju, Pratik S Upadhyay, DDC, Priscilla M Pastrana, R Edwadebey Deberry, Rachael L Cook, Radona R Boutte, Randy L Clarida, Reba A Gates, Rebecca Rodriguez, Rhonda Alexander, Richard L Garcia, Robert C Coleman, Robert D Tollefsen, Robert L Lewis, Jr, Robert W Jennings, Robin N Goins, Rose M Ashley, Rose Xu, Russell K Riley, Saeid E Kazan, Samuel L Murray, Santos E Camara, Sarah L Holliday, Sayeeda Hdabe, Scott T Ballard, Seneca D Toms, Sharna D Pratt, Sharon K Thoma, PharmD, Shelby N Turner, Sherri N Rohlf, MD, Shirley S Brown, Sidney B Priesmeyer, Sonya M Edmonds, Srinivas R Chennamaneni, PhD, Srira Subramaniam, PhD, State Agency, Stephen D Eich, Steven Fong, MS, PhD, Steven J Rush, Steven M Weinman, Susan M Jackson, Susan O Oladeji, Suzanne N Vallez, Tajah L Blackburn, Tamara M Casselman, Tamara M Felton, Tamika D Cathey, Tamil Arasu, PhD, Tammara A Stephens, Teresa C Thompson, Thomas J Arista, Thomas R Barry, Thomas R Binay, Thomas R Withers, Thuy T Nguyen, LCDR, Tomika L Bivens, Tonshina R Hall, Tracy K Bell, Tracy L Ramseur, Tracy R Ball, Trang N Cox, Tsedenia Woldehanna, Ucheabuchi C Chudi Nwankwor, Vanessa E Coulter, Veronica Fuentes, MS, Vicky C Stoakes, Victor J Gangi, Viviana Matta, Washington, Wayne E Seifert, William P Tonkins, Williams, Xiomara Copeland, Yiyue Zhang (nmi), PhD, Yumi J Hiramine, Yun Wu, PhD, Zhao Wang, PhD, Zhihao Qiu (Peter), PhD, Zhong Li, PhD

CDR Thomas R Berry, PPh's Documents

Publish Date Document Type Title
August, 2004 FDA 483 SpecGx LLC - Form 483, 2004-08-05
August, 2004 EIR SpecGx LLC - EIR, 2004-08-05
June, 2007 EIR GlaxoSmithKline LLC - EIR, 2007-06-12
June, 2006 FDA 483 Sagent Pharmaceuticals, Inc. - Form 483, 2006-06-02
January, 2008 EIR AM2 PAT INC - EIR, 2008-01-16
June, 2006 FDA 483 GlaxoSmithKline LLC - Form 483, 2006-06-16
September, 2007 FDA 483 The Ritedose Corporation - Form 483, 2007-09-14
March, 2005 EIR Hospira, Inc. - EIR, 2005-03-24
September, 2008 FDA 483 Novo Nordisk Pharmaceutical Industries, LP - Form 483, 2008-09-26
April, 2005 FDA 483 Eisai Inc - Form 483, 2005-04-29
March, 2008 EIR East Coast Medical Oxygen, Inc - EIR, 2008-03-26
January, 2006 FDA 483 Dudley Products Inc - Form 483, 2006-01-30
February, 2004 FDA 483 Societal CDMO Gainesville, LLC - Form 483, 2004-02-20
September, 2007 EIR Novo Nordisk Pharmaceutical Industries, LP - EIR, 2007-09-28
September, 2007 EIR The Ritedose Corporation - EIR, 2007-09-14
February, 2004 FDA 483 Response Societal CDMO Gainesville, LLC - Form 483R, 2004-03-09
September, 2006 EIR Novo Nordisk Pharmaceutical Industries, LP - EIR, 2006-09-22
April, 2004 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2004-04-02
March, 2004 FDA 483 Patheon Softgels Inc. - Form 483, 2004-03-15
September, 2003 FDA 483 PPD Development LP - Form 483, 2003-09-25
January, 2010 FDA 483 Hospira, Inc. - Form 483, 2010-01-19
October, 2004 EIR Novo Nordisk Pharmaceutical Industries, LP - EIR, 2004-10-01
January, 2008 FDA 483 AM2 PAT INC - Form 483, 2008-01-16
March, 2006 EIR Novo Nordisk Pharmaceutical Industries, LP - EIR, 2006-03-21
December, 2003 EIR Alcami Carolinas Corporation - EIR, 2003-12-03
January, 2003 EIR Patheon Manufacturing Services LLC - EIR, 2003-01-22
October, 2002 EIR GlaxoSmithKline LLC - EIR, 2002-10-17
July, 2003 EIR Patheon Manufacturing Services LLC - EIR, 2003-07-18
December, 2002 EIR Hospira, Inc. - EIR, 2002-12-10
May, 2008 EIR The Procter & Gamble Manufacturing Company - EIR, 2008-05-09
August, 2009 EIR GlaxoSmithKline LLC - EIR, 2009-08-24
October, 2003 FDA 483 Alcami Carolinas Corporation - Form 483, 2003-10-31
March, 2008 FDA 483 East Coast Medical Oxygen, Inc - Form 483, 2008-03-26
July, 2007 EIR Deston Therapeutics, Llc - EIR, 2007-07-17
September, 2006 EIR GlaxoSmithKline - EIR, 2006-09-15
August, 2006 FDA 483 Liebel-Flarsheim Company LLC - Form 483, 2006-08-08
July, 2003 EIR PPD Medical Communications - EIR, 2003-07-07
September, 2006 FDA 483 Response Novo Nordisk Pharmaceutical Industries, LP - Form 483R, 2006-10-09
October, 2007 EIR Patheon Softgels Inc. - EIR, 2007-10-15
April, 2003 FDA 483 Liebel-Flarsheim Company LLC - Form 483, 2003-04-18
January, 2005 EIR Drug Safety Alliance - EIR, 2005-01-14
July, 2007 EIR Deston Therapeutics, Llc - EIR, 2007-07-17
November, 2007 FDA 483 GlaxoSmithKline - Form 483, 2007-11-13
August, 2005 EIR Hospira, Inc. - EIR, 2005-08-18
September, 2009 FDA 483 CSL Plasma, Inc - Form 483, 2009-09-18
April, 2008 EIR Stiefel Research Institue Inc - EIR, 2008-04-22
June, 2004 EIR Carolina Pharmaceuticals, Inc. - EIR, 2004-06-04
May, 2003 FDA 483 Biovail Pharmaceuticals Inc. - Form 483, 2003-05-05
March, 2004 EIR Patheon Softgels Inc. - EIR, 2004-03-15
May, 2007 EIR Catalent Pharma Solutions, LLC - EIR, 2007-05-09
April, 2004 FDA 483 Response Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2004-04-29
July, 2004 FDA 483 Ajinomoto Health & Nutrition North America, Inc. - Form 483, 2004-07-21
June, 2008 FDA 483 Hospira, Inc. - Form 483, 2008-06-13
February, 2010 FDA 483 Hospira, Inc. - Form 483, 2010-02-23
February, 2004 EIR Societal CDMO Gainesville, LLC - EIR, 2004-02-20
February, 2007 EIR Patheon Manufacturing Services LLC - EIR, 2007-02-05
March, 2004 FDA 483 Response Patheon Softgels Inc. - Form 483R, 2004-03-26
February, 2010 EIR Hospira, Inc. - EIR, 2010-02-23
July, 2007 FDA 483 Deston Therapeutics, Llc - Form 483, 2007-07-17
July, 2007 EIR Deston Therapeutics, Llc - EIR, 2007-07-17
April, 2009 FDA 483 Synthon Pharmaceuticals, Inc - Form 483, 2009-04-03
August, 2003 EIR GlaxoSmithKline - EIR, 2003-08-07
October, 2007 FDA 483 Patheon Softgels Inc. - Form 483, 2007-10-15
May, 2008 EIR Del Pharmaceuticals, Inc. - EIR, 2008-05-30
August, 2008 EIR Baxter Healthcare Corporation - EIR, 2008-08-21
April, 2006 FDA 483 CMP Pharma, Inc. - Form 483, 2006-04-28

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more